Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
Investigators aimed to test the beneficial effect of tirofiban, a GPIIb/IIIa antagonist, for
Non-ST-Elevation Acute Coronary Syndrome Patients who has high resistance to clopidogrel.